ABVC BioPharma Closes $3.39 Million Convertible Note Offering and Settles Financing Dispute

Article summary

ABVC BioPharma closed a private placement of senior convertible notes for $3.39 million in gross proceeds and reached a $625,000 settlement with Lind Global Fund II to resolve outstanding litigation.